antibiotic/inflammation

FIELD OF THE INVENTION This invention relates to novel antibacterial and anti-inflammatory benzylphenol compounds, which compounds find useful application when used in oral compositions to provide enhanced antiplaque, antigingivitis and anti-periodontal disease benefits. BACKGROUND OF THE

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a U.S. national phase application under the provisions of 35 U.S.C. .sctn.371 of International Patent Application No. PCT/KR2011/004300 filed Jun. 13, 2011, which in turn claims priority of Korean Patent Application No. 10-2010-0057000

FIELD A medicinal composition having antibiotic, anti-inflammatory, and wound healing activity, and in particular, a medicinal composition that inhibits the growth of pathogens by means of a synergistic and unexpected association of plant extracts of Matricaria recutita, Psidium guajava L., and

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to a natural cell control carrier, more specifically to a natural cell control carrier comprising water-soluble chitosan (HFP) and elecampane (Inula Helenium L.) extract, which solves problems of conventional

FIELD OF THE INVENTION The present invention relates to 5-ASA derivatives and methods of treating diseases therewith. BACKGROUND OF THE INVENTION Many people suffer from inflammatory bowel disease (IBD). TRD is a generic term used to refer to two inflammatory diseases, ulcerative colitis and Crohn's

The present invention relates to a novel solid therapeutic composition consisting of an association of collagen with an antiseptic and/or antiinflammatory active principle, for the treatment of periodontal diseases, in particular for the treatment of deep or superficial periodontal pockets. The

CROSS-REFERENCE TO RELATED APPLICATION This application claims the benefit of earlier filing date and right of priority to Korean Application No. 10-2017-0037935, filed on Mar. 24, 2017, the contents of which is incorporated by reference herein in its entirety. FIELD The present invention relates to

This invention was made with Government support under R37 DE03987 awarded by National Institute of Dental Research [NIH]. The Government has certain rights in the invention. The present invention relates to an anti-collagenolytic composition useful in the treatment of rheumatoid arthritis and other

The present invention relates to an anti-collagenolytic composition useful in the treatment of rheumatoid arthritis and other tissue-destructive conditions associated with excess collagenolytic activity as well as a method for using such formulations. BACKGROUND OF THE INVENTION Tetracyclines

The invention concerns preparations for the application of agents with anti-inflammatory, especially antiseptic and/or wound healing promoting properties to the lower respiratory tract. The preparations are specifically applied to trachea, bronchi and alveoli in the lower respiratory tracts of

FIELD OF INVENTION The present invention relates generally to compositions and methods for the prophylaxis and treatment of inflammatory bowel disease (IBD) due to bacterial infection. More specifically, this invention envisions the use of probiotic formulations in combination with antibiotics to

FIELD OF INVENTION The present invention relates generally to compositions and methods for the prophylaxis and treatment of inflammatory bowel disease (IBD) due to bacterial infection. More specifically, this invention envisions the use of probiotic formulations in combination with antibiotics to

FIELD OF INVENTION The present invention relates generally to compositions and methods for the prophylaxis and treatment of inflammatory bowel disease (IBD) due to bacterial infection. More specifically, this invention envisions the use of probiotic formulations in combination with antibiotics to

BACKGROUND OF THE INVENTION The present invention relates to compositions including antibiotics and to methods for using such compositions. More particularly, the invention relates to compositions including antibiotics which have added protection against fungal contamination, which reduce

CROSS-REFERENCES TO RELATED APPLICATIONS This application is a U.S. national phase application of International PCT Patent Application No. PCT/KR2011/006094, which was filed on Aug. 18, 2011, which claims priority to Korean Patent Application Nos. 10-2010-0123086, filed Dec. 3, 2010;